Christopher Kobylecki

Long COVID: major findings, mechanisms and recommendations

Parkinson disease

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

An Adaptive Role of TNFα in the Regulation of Striatal Synapses

Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease

Endogenous Hypoxia Markers in Locally Advanced Cancers of the Uterine Cervix: Reality or Wishful Thinking?

Hypoxia in cancer: significance and impact on clinical outcome

Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

How to diagnose parkinsonian central pain?

De novo design of a homo-trimeric amantadine-binding protein

Neuropathic Pain: From Mechanisms to Treatment

Small‐fiber neuropathy: Expanding the clinical pain universe

The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease

Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study

Synaptic recruitment of AMPA glutamate receptor subunits in levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate

Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease

Calcium‐permeable AMPA receptors are involved in the induction and expression of l‐DOPA‐induced dyskinesia in Parkinson’s disease

Small Fibre Neuropathy in Parkinson’s Disease: Comparison of Skin Biopsies from the More Affected and Less Affected Sides